The new Renishaw RA816 Biological Analyser enables the rapid collection of detailed information from a range of biological samples, including tissue and biofluids. It enables biologists and clinicians to identify and assess biochemical changes associated with disease formation and progression. They can obtain the full range of biochemical information without needing prior knowledge of specific molecular targets or labelling or staining. The instrument obtains detailed information on the distribution and amount of biochemical species within biological samples, including tissue biopsies, tissue sections and biofluids. Users are able to reveal detailed information from biological samples; from the distribution of exogenous and endogenous compounds within tissue, to the detection of protein secondary structure changes due to drug interaction and tissue injury.
Renishaw’s RA816 Biological Analyser has been extensively tested at multiple locations including the Neuro-oncology Department at Oxford Radcliffe Hospital, UK and Humanitas Hospital in Milan, Italy, where they have been studying brain tissue for the genetic classification of glioma tumours. The analyser has the potential to aid surgeons in tailoring their surgical strategy based on a patient’s specific tumour genetics.
